
LeronLimab Times - Reddit
All News and discussion board regarding @Cytodyn and #LeronLimab Developments. No misinformation! No Lies! No Insults! No Personal Attacks! No Conspiracy Theories! Only …
Do we want CYDY to get bought out for $10.8 Billion? Thats
Jun 2, 2023 · Do we want CYDY to get bought out for $10.8 Billion? Thats what Merck paid for Prometheus! Big Thank you to Ok-Eye and SunrayDoc for recent posts on LT about M&A in …
A New Beginning/Rebirth of CYDY : r/Livimmune - Reddit
CYDY has cleared a path forward and now has to execute to get to eventual commercialization/FDA approval. WE WILL GET THERE!! Today is just the beginning of …
r/Livimmune - Reddit
r/Livimmune: CYDY/Leronlimab discussions. Unofficial.Introduction: In the dynamic landscape of drug development, every twist and turn presents both challenges and opportunities. The …
Welcome! : r/CYDY - Reddit
Jan 31, 2021 · Welcome to the CYDY subreddit! We are on the cusp of achieving something special. The results of the CD12 trial will be out and will show that leronlimab reduces mortality …
Report: My experience with Chinese TPU tubes : r/cycling - Reddit
This is a report on my experience and personal conclusion on Chinese TPU tubes, which I hope some of you guys might find useful. 3 months ago, I…
CytoDyn Stock: Moving Leronlimab Forward On All Fronts (CYDY
21 votes, 70 comments. 4.3K subscribers in the CYDY community. All things regarding CytoDyn and their blockbuster drug Leronlimab.
Buyout question : r/CYDY - Reddit
Aug 7, 2021 · CYDY has a lot of irons in the fire but none that are ready yet. Each indication adds value but the key is getting that first approval as that greatly derisks the potential of LL. Until …
Cytodyn - Reddit
CYDY forum on Reddit takes full control and kick all People out that send messages that are critical to the 13D group. Investors should check different groups now and vote them totally out.
Bristol Myers and Merck are in a race. : r/CYDY - Reddit
Aug 11, 2023 · Great conversation with the R&D person. Innovation does exist but not necessarily in the Big houses of the Pharmaceutical world. They need to look at unencumbered …